|
1.
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
2.
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: from dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
4.
|
Pao W and Girard N: New driver mutations
in non-small-cell lung cancer. Lancet Oncol. 12:175–180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Choi H, Kratz J, Pham P, et al:
Development of a rapid and practical mutation screening assay for
human lung adenocarcinoma. Int J Oncol. 40:1900–1906.
2012.PubMed/NCBI
|
|
6.
|
Vogelstein B, Fearon ER, Hamilton SR, et
al: Genetic alterations during colorectal-tumor development. N Engl
J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Barrett JC: Mechanisms of multistep
carcinogenesis and carcinogen risk assessment. Environ Health
Perspect. 100:9–20. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Rudin CM, Durinck S, Stawiski EW, et al:
Comprehensive genomic analysis identifies SOX2 as a frequently
amplified gene in small-cell lung cancer. Nat Genet. 44:1111–1116.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Imielinski M, Berger AH, Hammerman PS, et
al: Mapping the hallmarks of lung adenocarcinoma with massively
parallel sequencing. Cell. 150:1107–1120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Bosco-Clément G, Zhang F, Chen Z, et al:
Targeting gli transcription activation by small molecule suppresses
tumor growth. Oncogene. May 20–2013.(Epub ahead of print).
|
|
12.
|
Irizarry RA, Hobbs B, Collin F, et al:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar
|
|
13.
|
Saunders CT, Wong WS, Swamy S, et al:
Strelka: accurate somatic small-variant calling from sequenced
tumor-normal sample pairs. Bioinformatics. 28:1811–1817. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Cibulskis K, Lawrence MS, Carter SL, et
al: Sensitive detection of somatic point mutations in impure and
heterogeneous cancer samples. Nat Biotechnol. 31:213–219. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wang K, Li M and Hakonarson H: ANNOVAR:
functional annotation of genetic variants from high-throughput
sequencing data. Nucleic Acids Res. 38:e1642010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Li H, Handsaker B, Wysoker A, et al: The
sequence alignment/map format and samtools. Bioinformatics.
25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Sathirapongsasuti JF, Lee H, Horst BA, et
al: Exome sequencing-based copy-number variation and loss of
heterozygosity detection: ExomeCNV. Bioinformatics. 27:2648–2654.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Mao JH, Kim IJ, Wu D, et al: FBXW7 targets
mTOR for degradation and cooperates with PTEN in tumor suppression.
Science. 321:1499–1502. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Wang X, Zhou C, Qiu G, et al:
Phospholipase c epsilon plays a suppressive role in incidence of
colorectal cancer. Med Oncol. 29:1051–1058. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Danielsen SA, Cekaite L, Ågesen TH, et al:
Phospholipase c isozymes are deregulated in colorectal
cancer-insights gained from gene set enrichment analysis of the
transcriptome. PLoS One. 6:e244192011. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Redon R, Ishikawa S, Fitch KR, et al:
Global variation in copy number in the human genome. Nature.
444:444–454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Grarup N, Andersen G, Krarup NT, et al:
Association testing of novel type 2 diabetes risk alleles in the
jazf1, cdc123/camk1d, tspan8, thada, adamts9, and notch2 loci with
insulin release, insulin sensitivity, and obesity in a
population-based sample of 4,516 glucose-tolerant middle-aged
Danes. Diabetes. 57:2534–2540. 2008. View Article : Google Scholar
|
|
23.
|
Zeggini E, Scott LJ, Saxena R, et al:
Meta-analysis of genome-wide association data and large-scale
replication identifies additional susceptibility loci for type 2
diabetes. Nat Genet. 40:638–645. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Gateva V, Sandling JK, Hom G, et al: A
large-scale replication study identifies tnip1, prdm1, jazf1,
uhrf1bp1 and il10 as risk loci for systemic lupus erythematosus.
Nat Genet. 41:1228–1233. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Chiang S, Ali R, Melnyk N, et al:
Frequency of known gene rearrangements in endometrial stromal
tumors. Am J Surg Pathol. 35:1364–1372. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Soda M, Choi YL, Enomoto M, et al:
Identification of the transforming EML4-ALK fusion gene in
non-small-cell lung cancer. Nature. 448:561–566. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Holzinger A, Maier EM, Bück C, et al:
Mutations in the proenteropeptidase gene are the molecular cause of
congenital enteropeptidase deficiency. Am J Hum Genet. 70:20–25.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Bergethon K, Shaw AT, Ou SH, et al: ROS1
rearrangements define a unique molecular class of lung cancers. J
Clin Oncol. 30:863–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Oxnard GR, Binder A and Jänne PA: New
targetable oncogenes in non-small-cell lung cancer. J Clin Oncol.
31:1097–1104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Awad MM, Katayama R, McTigue M, et al:
Acquired resistance to crizotinib from a mutation in CD74-ROS1. N
Engl J Med. 368:2395–2401. 2013. View Article : Google Scholar : PubMed/NCBI
|
